1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. UROGEN PHARMA LTD
UroGen Pharma Ltd
XNAS: URGN
43.20 -0.05 (-0.12%)
482.4K
XNAS Volume

XNAS 21 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

UroGen Pharma Ltd - URGN - stock price prediction, stock price target, analyst ratings from 8 analysts

UroGen Pharma Ltd has a share price target of US$ 60, revenue growth forecast of 193.5%, and profit growth estimate of 94.0% for FY26, based on top 8 analyst calls.